It’s important to know AAFCO pet food ingredient definitions and nuances; otherwise inaccurate conclusions can result, such as with the DCM investigation.

To avoid DCM and future problems, pet food formulators may need to reevaluate what humanization means in terms of ingredient diversity.

After near silence on the DCM and grain-free pet food investigation and no real updates for a year, FDA has issued statements that raise more questions.

In October 2020, Petfood Industry’s editors and columnists wrote 14 blogs or feature articles, which covered AAFCO, apples, ownership trends and dilated cardiomyopathy.

Officials with the U.S. Food and Drug Administration Center for Veterinary Medicine released several documents and statements about the agency’s investigation into correlations between specific dog foods and cases of canine dilated cardiomyopathy.

FDA’s recent, very quiet update on its grain-free pet food-DCM investigation showed that, no surprise, it’s a complex issue that can’t be pinned to one cause.

Scientists continue searching for the ultimate cause of the DCM cases that the FDA is investigating.

As the pet food market emerges from a difficult year and economic situation, certain product categories present opportunities for innovation and growth.

While scientists still have much to learn about what causes dilated cardiomyopathy (DCM) in dogs, pet food companies do have tools to deal with DCM while researchers look for answers.

Among more than 150 published studies related to DCM, researchers didn’t find any firm connection among cases of DCM and grain-free dog food.